Getinge (OTCMKTS:GNGBY) Shares Up 9.2% – Here’s Why

Getinge (OTCMKTS:GNGBY) shares rose 9.2% during trading on Monday . The company traded as high as $23.70 and last traded at $23.70. Approximately 111 shares traded hands during trading, a decline of 97% from the average session volume of 3,449 shares. The stock had previously closed at $21.70.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Getinge to a “hold” rating in a report on Thursday, April 23rd. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

Getinge Price Performance

The company has a quick ratio of 0.86, a current ratio of 1.32 and a debt-to-equity ratio of 0.27. The stock’s 50-day moving average price is $20.65 and its 200-day moving average price is $21.33. The company has a market capitalization of $6.49 billion, a price-to-earnings ratio of 22.70 and a beta of 0.96.

Getinge (OTCMKTS:GNGBY) last issued its quarterly earnings results on Friday, July 17th. The company reported $0.38 earnings per share for the quarter. Getinge had a net margin of 7.81% and a return on equity of 11.67%. The business had revenue of $894.87 million during the quarter. Equities research analysts anticipate that Getinge will post 1.33 earnings per share for the current year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.